Faculty Bio - Jong-Hyeon Jeong, PhD
Associate Professor, Biostatistics
Statistician,
NSABP
Education
BA, Kang-Weon National University
MA, University of Rochester
PhD, University of Rochester
Research Interests
Dr. Jeong's main research area has been survival analysis and clinical trials. In survival analysis, he has worked on frailty modeling, efficiency of survival probability estimates from the proportional hazards model, weighted log-rank test, competing risks, quantile residual lifetime, and empirical likelihood inference. In clinical trials, he has been involved in several phase III breast cancer clinical trials through the National Surgical Adjuvant Breast and Bowel Project (NSABP) as the primary statistician. He has graduated 5 MS and PhD students, and is currently advising 5 PhD students. He has been teaching statistical theory courses and survival analysis. Dr. Jeong holds his PhD degree in statistics from the University of Rochester and has been an elected member of the International Statistical Institute (ISI) since 2007.
Membership
Elected member, International Statistical Institute (ISI)
Member, American Statistical Association
Member, The International Biometric Society/Eastern North American Region (ENAR)
Courses
BIOST 2043: Introduction to Statistical Theory I
BIOST 2044: Introduction to Statistical Theory II
BIOST 2049: Applied Regression Analysis
BIOST 2051: Statistical Estimation Theory
BIOST 2054/STAT 2261: Survival Analysis
Selected Publications
Methodology Papers:
Oakes, D. and Jeong, J. (1998). Frailty models and rank tests. Lifetime Data Analysis 4, 209 228.
Jeong, J. and Oakes, D. (2003). On the asymptotic relative efficiency of estimates from Cox’s model. Sankhya 65, 411-421.
Jeong, J. and Jung, S. (2006). Rank tests for clustered survival data when dependent subunits are randomized. Statistics in Medicine 25, 361-373.
Jeong, J. and Fine, J. (2006). Direct parametric inference for cumulative incidence function. Journal of Royal Statistical Society-Series C (Applied Statistics) 55, 187-200.
Jeong, J. (2006). A new parametric distribution for modeling cumulative incidence function: Application to breast cancer data. Journal of Royal Statistical Society -Series A (Statistics in Society) 169, 289-303.
Jeong, J. and Fine, J. (2007). Parametric regression on cumulative incidence function. Biostatistics 8, 184-196.
Jeong, J., Jung, S, and Joseph Costantino. (2008). Nonparametric inference on median residual lifetimes in breast cancer patients. Biometrics 64, 157-163.
Jeong, J. and Fine, J.P. (2009). A note on cause-specific residual life. Biometrika, 96, 237-242.
Jung, S, Jeong, J., and Bandos, H. (2009). Regression on quantile residual life. Biometrics, 65, 1203-1212.
Zhou, M. and Jeong, J. (2010). Empirical likelihood ratio test for median and mean residual lifetime. Statistics in Medicine 30, 152-159.
Tang, S. and Jeong, J. (2012). Median tests for censored survival data; contingency table approach. Biometrics, DOI:10.1111/j.1541-0420.2011.01723.x
Collaborative Papers:
Fisher, B, Jeong, J., Anderson, S. Bryant, J., Fisher, E., and Wolmark Norman. (2002). Twenty-five year findings from a randomized clinical trial comparing radical mastectomy with total mastectomy and with total mastectomy followed by radiation therapy. The New England Journal of Medicine, 347, 567-575.
Fisher, B., Jeong, J., Bryant, J., Mamounas, E.P., Dignam, J., and Wolmark, N. (2004). Treatment of lymph node-negative, estrogen receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. The Lancet 364, 858-868.
Fisher, B, Jeong, J. Anderson, S., et al. (2004). Treatment of lymph node-negative, estrogen receptor-negative breast cancer: Long-term findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. Journal of the National Cancer Institute 96, 1823-1831.
Taghian, A., Jeong, J., Mamounas, E., Parda, D.M., Deutsch, M., Costantino, J.P., and Wolmark, N. (2006). Low loco-regional recurrence rate among node negative breast cancer patients with tumor size 5cm and larger treated by mastectomy with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Journal of Clinical Oncology 24, 3937-3932.
Mamounas, M., Jeong, J.,Wickerham, L. et al. (2008). Benefit from exemestane as extended Adjuvant therapy after five years of tamoxifen: results from the NSABP B-33 trial. Journal of Clinical Oncology 26, 1965-1971.
Swain, S.M., Jeong, J., and Geyer, C.E. et al. (2010). Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. The New England Journal of Medicine, 362, 2053-2065.
Contact Information
318B Parran Hall
130 DeSoto Street
Pittsburgh, PA 15261
Telephone: 412-624-8549
Facsimile: 412-624-2183
Email: jeong@nsabp.pitt.edu
Last reviewed: January 19, 2012
